Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
John, Joseph F.
2000.
Antibiotic Cycling: Is It Ready for Prime Time?.
Infection Control & Hospital Epidemiology,
Vol. 21,
Issue. 1,
p.
9.
McGowan, J. E.
2000.
The Impact of Changing Pathogens of Serious Infections in Hospitalized Patients.
Clinical Infectious Diseases,
Vol. 31,
Issue. Supplement 4,
p.
S124.
Andremont, Antoine
2001.
The future control of bacterial resistance to antimicrobial agents.
American Journal of Infection Control,
Vol. 29,
Issue. 4,
p.
256.
McGowan, John E.
2001.
Economic Impact of Antimicrobial Resistance.
Emerging Infectious Diseases,
Vol. 7,
Issue. 2,
p.
286.
Andremont, A.
2002.
Pression de sélection antibiotique, flores commensales et évolution de la résistance.
Journal de Pédiatrie et de Puériculture,
Vol. 15,
Issue. 3,
p.
160.
Reed, Shelby D
Laxminarayan, Ramanan
Black, Doug J
and
Sullivan, Sean D
2002.
Economic Issues and Antibiotic Resistance in the Community.
Annals of Pharmacotherapy,
Vol. 36,
Issue. 1,
p.
148.
El-Sukhon, Saeb Nazmi
and
Faiza Boukhatem, Zineb
2003.
Activity of combinations of ceftazidime, imipenem and pefloxacin against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.
International Journal of Antimicrobial Agents,
Vol. 22,
Issue. 6,
p.
613.
Niederman, Michael S.
2003.
Appropriate use of antimicrobial agents: Challenges and strategies for improvement.
Critical Care Medicine,
Vol. 31,
Issue. 2,
p.
608.
López, Horacio
Li, Jim Z.
Balan, Dan A.
Willke, Richard J.
Rittenhouse, Brian E.
Mozaffari, Essy
Vidal, Gabriela
Zitto, Teresa
and
Tang, Tom
2003.
Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: Results from a multicenter trial.
Clinical Therapeutics,
Vol. 25,
Issue. 6,
p.
1846.
Dowell, Scott F
2004.
Antimicrobial resistance: is it really that bad?.
Seminars in Pediatric Infectious Diseases,
Vol. 15,
Issue. 2,
p.
99.
Masterton, Robert G.
2005.
Antibiotic cycling: more than it might seem?.
Journal of Antimicrobial Chemotherapy,
Vol. 55,
Issue. 1,
p.
1.
Hurdle, Julian Gregston
O'Neill, Alexander John
and
Chopra, Ian
2005.
Prospects for Aminoacyl-tRNA Synthetase Inhibitors as New Antimicrobial Agents.
Antimicrobial Agents and Chemotherapy,
Vol. 49,
Issue. 12,
p.
4821.
Pope, Scott D
and
Roecker, Andrew M
2006.
Dalbavancin: A Novel Lipoglycopeptide Antibacterial.
Pharmacotherapy,
Vol. 26,
Issue. 7,
p.
908.
Roecker, Andrew M
and
Pope, Scott D
2008.
Dalbavancin: a lipoglycopeptide antibacterial for Gram-positive infections.
Expert Opinion on Pharmacotherapy,
Vol. 9,
Issue. 10,
p.
1745.